Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: ACP-01 in Patients With Critical Limb Ischemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for ACP-01 in patients with critical limb ischemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACP-01

Snippet

Sponsor: Hemostemix | Conditions: Critical Limb Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2023-11-18